RankingsPricing
  1. JP-listed companies
  2. Chiome Bioscience Inc.
  3. Financials
  4. Retained earnings

Chiome Bioscience Inc.JP:4583

Market cap
¥7.5B
P/E ratio
SummaryFinancialsHistoryOwnershipWorkforce
Period EndRetained earnings (Million JPY)YoY (%)
Dec 31, 2024-1,021-80.51%
Dec 31, 2023-5,236+30.38%
Dec 31, 2022-4,016+44.80%
Dec 31, 2021-2,774+114.38%
Dec 31, 2020-1,294-86.60%
Dec 31, 2019-9,655+17.01%
Dec 31, 2018-8,251+22.83%
Dec 31, 2017-6,717+15.13%
Dec 31, 2016-5,835+34.33%
Dec 31, 2015-4,344+41.91%
Dec 31, 2014-3,061

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)